Synthesis and biological evaluation of 2-(2-methyl-1H-pyrrol-3-yl)-2-oxo-N-(pyridine-3-yl) acetamide derivatives: in vitro α-glucosidase inhibition, and kinetic and molecular docking study
- 13 Downloads
One of the therapeutic approaches in the management of type 2 diabetes is delaying the glucose absorption through α-glucosidase enzyme inhibition, which can reduce the occurrence of postprandial hyperglycemia. Based on this thought, a series of novel chloro-substituted 2-(2-methyl-1-phenyl-1H-pyrrol-3-yl)-2-oxo-N-(pyridin-3-yl) acetamide derivatives 5a–i were synthesized and their α-glucosidase inhibitory activities were evaluated. All the synthesized compounds have shown moderate to excellent in vitro α-glucosidase inhibitory activity with IC50 values in the range of 111–673 µM) as compared to acarbose, the standard drug (750 ± 9 µM). Compound 5e (111 ± 12 µM), among the series, was the most potent inhibitor of α-glucosidase in a competitive mode of action based on the kinetic study. The molecular docking study of compounds 5e and 5a revealed that they have a lower free binding energy (− 4.27 kcal/mol and − 3.17 kcal/mol, respectively) than acarbose (− 2.47 kcal/mol), which indicates that the target compound binds more easily to the enzyme than acarbose does. The outcomes from the molecular docking studies supported the results obtained from the in vitro assay. In conclusion, the overall results of our study reveal that the synthesized compounds could be a potential candidate in the search for novel α-glucosidase inhibitors to manage postprandial hyperglycemia incidence.
Keywordsα-Glucosidase activity Docking Kinetic study Synthesis Pyrrole
This research was supported by a grant from Tehran University of Medical Sciences (GN: 39750).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B (2009) The carbohydrate-active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res 54:7759–7771Google Scholar
- Ghasemi Y, Mehraban MH (2015) A computational comparative study of α-Glucosidase enzyme divergence. J Appl Bioinform Comput Biol 4:2–5Google Scholar
- Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS (2008) Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents. Eur J Med Chem 43:1989–1996PubMedCrossRefGoogle Scholar
- Nikookar H, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Ranjbar PR, Mahdavi M, Larijani B (2018) Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents. Bioorg Chem 77:280–286PubMedCrossRefGoogle Scholar
- Powers AC (2015) Diabetes mellitus: diagnossis, classification and pathophysiology. Harrison’s Principles of Internal Medicine.19th edn. The McGraw-Hill Companies, pp 2275–2304Google Scholar
- Ramprasad R, Madhusudhan S (2016) In vitro–amylase and–glucosidase inhibitory activities of ethanolic extract of Lactuca runcinata DC. Der Pharmacia Lett 8:231–236Google Scholar
- Rhodes G (2006) Crystallography made crystal clear. Elsevier, Burlington, USAGoogle Scholar
- Sun H, Ding W, Song X, Wang D, Chen M, Wang K et al (2017) Synthesis of 6-hydroxyaurone analogues and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity: development of highly active 5,6-disubstituted derivatives. Bioorg Med Chem Lett 27:3226–3230PubMedCrossRefGoogle Scholar
- World Health Organization (2016) Global report on diabetes. World Health Organization. https://apps.who.int/iris/handle/10665/204871/. Accessed 24 Feb 2018